Through advocacy, program development, and education we aim to improve the quality of life for the over 136 million Americans living with diabetes or prediabetes
Practices that proactively address this through transparent pricing, flexible payment plans, manufacturer copay assistance programs for GLP-1 medications, and clearly communicated value propositions see significantly higher conversion rates from consultation to program enrollment
Trends in Pharmacological Sciences , 29 (8), 375382
The trial in people with T2D included 281 participants (mean age 56 years, 56% women, mean BMI 35.0 kg/m 2 , mean HbA1c 8.3%) treated with lifestyle only and/or metformin, with similar intervention arms to the obesity trial, albeit retatrutide 0.5 mg rather than 1 mg, and dulaglutide 1.5 mg was an additional comparator [46]
Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al